At a Glance
| Efavirenz | 1cP-AL-LAD | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Routes | smoked | oral |
| Effects | 41 documented | 72 documented |
| Interaction | Low Risk & Synergy | |
Dosage
Only in Efavirenz
smoked
| Level | Dose |
|---|---|
| Common | 600–1800 mg |
Only in 1cP-AL-LAD
oral
| Level | Dose |
|---|---|
| Threshold | 20 µg |
| Light | 50–100 µg |
| Common | 100–225 µg |
| Strong | 225–350 µg |
| Heavy | 350 µg |
Duration
Only in Efavirenz
smoked
Peak
Afterglow
Onset1 min – 5 min
Peak1 hrs – 2 hrs
Afterglow6 hrs – 12 hrs
Only in 1cP-AL-LAD
oral
Total: 7 hrs – 10 hrsEffects
Safety
Interaction: Efavirenz + 1cP-AL-LAD
Low Risk & Synergy
Cross-tolerance exists; effects compound
Efavirenz — Dangerous Interactions
No dangerous interactions recorded.
1cP-AL-LAD — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between Efavirenz and 1cP-AL-LAD?
Efavirenz is classified as a Psychedelic (Benzoxazine) while 1cP-AL-LAD is classified as a Psychedelic (Lysergamides). They share 32 effects in common, with 9 effects unique to Efavirenz and 40 unique to 1cP-AL-LAD.
Is it safe to combine Efavirenz and 1cP-AL-LAD?
The interaction between Efavirenz and 1cP-AL-LAD is classified as "Low Risk & Synergy". Cross-tolerance exists; effects compound Always research interactions thoroughly before combining any substances.
Which is stronger, Efavirenz or 1cP-AL-LAD?
Efavirenz and 1cP-AL-LAD are typically administered via different routes, making a direct potency comparison difficult. They belong to different pharmacological profiles and should not be compared by dose alone.